Lung Cancer

>

CURE’s lung cancer page is an extensive resource of cancer information featuring the latest lung cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on lung cancer.

Latest News

Optune Lua received a CE Mark for metastatic non–small cell lung cancer with immune checkpoint inhibitors or docetaxel.
Optune Lua Receives CE Mark in Europe for Metastatic NSCLC

April 23rd 2025

Optune Lua received a CE Mark for metastatic non–small cell lung cancer with immune checkpoint inhibitors or docetaxel.

Among patients with advanced squamous NSCLC, ivonescimab plus chemo was associated with positive progression-free survival results: © Steph_photagraphies - stock.adobe.com.
Ivonescimab Plus Chemo May Slow Advanced NSCLC Progression

April 23rd 2025

Image of Lungs.
First Patient Dosed in a Phase 1/2 Trial for Small Cell Lung Cancer

April 18th 2025

More News